Christina Schlecker

831 total citations · 1 hit paper
19 papers, 605 citations indexed

About

Christina Schlecker is a scholar working on Pulmonary and Respiratory Medicine, Hepatology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Christina Schlecker has authored 19 papers receiving a total of 605 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 5 papers in Hepatology and 3 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Christina Schlecker's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers), Hepatitis C virus research (5 papers) and Systemic Lupus Erythematosus Research (3 papers). Christina Schlecker is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers), Hepatitis C virus research (5 papers) and Systemic Lupus Erythematosus Research (3 papers). Christina Schlecker collaborates with scholars based in Germany, United States and Japan. Christina Schlecker's co-authors include Jörn Lötsch, Alexandra Doehring, Christoph Sarrazin, Tobias Müller, Eva Herrmann, Thomas Berg, S. Süsser, Christian M. Lange, Klara Szigeti‐Buck and Yogendra Sharma and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Investigation and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Christina Schlecker

18 papers receiving 592 citations

Hit Papers

Nerandomilast in Patients... 2025 2026 2025 5 10 15 20 25
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Nerandomilast in Patients with Idiopathic Pulmonary Fibrosis
    2025 28 citations Luca Richeldi, Arata Azuma et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christina Schlecker Germany 13 245 205 168 93 72 19 605
Giorgia Valle Italy 13 215 0.9× 193 0.9× 633 3.8× 57 0.6× 165 2.3× 16 946
Richard M. Roman United States 17 79 0.3× 45 0.2× 535 3.2× 33 0.4× 146 2.0× 17 1.1k
Pascale Bellaud France 14 49 0.2× 47 0.2× 341 2.0× 8 0.1× 28 0.4× 21 622
Scott M. Seki United States 13 65 0.3× 87 0.4× 243 1.4× 3 0.0× 36 0.5× 18 960
Shintaro Okada Japan 12 61 0.2× 103 0.5× 243 1.4× 4 0.0× 33 0.5× 27 582
Sung‐Kyun Moon South Korea 10 35 0.1× 23 0.1× 148 0.9× 184 2.0× 8 0.1× 19 476
Neomi Zurgil Israel 14 58 0.2× 67 0.3× 200 1.2× 6 0.1× 189 2.6× 23 567
B. Schwartz Israel 11 21 0.1× 82 0.4× 219 1.3× 17 0.2× 27 0.4× 23 507
Tao Yin China 15 28 0.1× 45 0.2× 201 1.2× 5 0.1× 33 0.5× 41 689
Eva Schmitteckert Germany 9 22 0.1× 79 0.4× 634 3.8× 5 0.1× 147 2.0× 9 823

Countries citing papers authored by Christina Schlecker

Since Specialization
Citations

This map shows the geographic impact of Christina Schlecker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christina Schlecker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christina Schlecker more than expected).

Fields of papers citing papers by Christina Schlecker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christina Schlecker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christina Schlecker. The network helps show where Christina Schlecker may publish in the future.

Co-authorship network of co-authors of Christina Schlecker

This figure shows the co-authorship network connecting the top 25 collaborators of Christina Schlecker. A scholar is included among the top collaborators of Christina Schlecker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christina Schlecker. Christina Schlecker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Richeldi, Luca, Arata Azuma, Vincent Cottin, et al.. (2025). Nerandomilast in Patients with Idiopathic Pulmonary Fibrosis. New England Journal of Medicine. 392(22). 2193–2202. 28 indexed citations breakdown →
2.
Richeldi, Luca, Arata Azuma, Vincent Cottin, et al.. (2025). Initiation of Supplemental Oxygen in the FIBRONEER-IPF Trial of Nerandomilast in Patients With Idiopathic Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine. 211(Supplement_1). A7047–A7047.
3.
Richeldi, Luca, Arata Azuma, Vincent Cottin, et al.. (2025). Phase III FIBRONEER-IPF Trial of Nerandomilast in Patients With Idiopathic Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine. 211(Supplement_1). A7993–A7993. 1 indexed citations
4.
Maher, Toby M., Shervin Assassi, Arata Azuma, et al.. (2023). Design of a phase III, double-blind, randomised, placebo-controlled trial of BI 1015550 in patients with progressive pulmonary fibrosis (FIBRONEER-ILD). BMJ Open Respiratory Research. 10(1). e001580–e001580. 16 indexed citations
5.
Desch, Michael, Christina Schlecker, Kathrin Hohl, et al.. (2023). Pharmacokinetic-Interactions of BI 425809, a Novel Glycine Transporter 1 Inhibitor, With Cytochrome P450 and P-Glycoprotein Substrates. Journal of Clinical Psychopharmacology. 43(2). 113–121. 2 indexed citations
6.
7.
8.
Rosenbrock, Holger, Michael Desch, Oliver Kleiner, et al.. (2018). Evaluation of Pharmacokinetics and Pharmacodynamics of BI 425809, a Novel GlyT1 Inhibitor: Translational Studies. Clinical and Translational Science. 11(6). 616–623. 33 indexed citations
9.
Moschetti, Viktoria, Christina Schlecker, Sven Wind, et al.. (2018). Multiple Rising Doses of Oral BI 425809, a GlyT1 Inhibitor, in Young and Elderly Healthy Volunteers: A Randomised, Double-Blind, Phase I Study Investigating Safety and Pharmacokinetics. Clinical Drug Investigation. 38(8). 737–750. 26 indexed citations
10.
Staecker, Hinrich, et al.. (2014). Optimizing atoh1‐induced vestibular hair cell regeneration. The Laryngoscope. 124(S5). S1–S12. 25 indexed citations
11.
Ferreirós, Nerea, et al.. (2013). Quantitation of ribavirin in human plasma and red blood cells using LC–MS/MS. Journal of Separation Science. 37(5). 476–483. 13 indexed citations
12.
Schlecker, Christina, Alfred Ultsch, Gerd Geißlinger, & Jörn Lötsch. (2012). The pharmacogenetic background of hepatitis C treatment. Mutation Research/Reviews in Mutation Research. 751(1). 36–48. 6 indexed citations
13.
Schlecker, Christina, Mark Praetorius, D E Brough, et al.. (2011). Selective atonal gene delivery improves balance function in a mouse model of vestibular disease. Gene Therapy. 18(9). 884–890. 65 indexed citations
14.
Doehring, Alexandra, Wolf Peter Hofmann, Christina Schlecker, et al.. (2011). Role of nucleoside transporters SLC28A2/3 and SLC29A1/2 genetics in ribavirin therapy. Pharmacogenetics and Genomics. 21(5). 289–296. 27 indexed citations
15.
Lötsch, Jörn, Wolf Peter Hofmann, Christina Schlecker, et al.. (2011). Single and Combined IL28B , ITPA and SLC28A3 Host Genetic Markers Modulating Response to Anti-hepatitis C Therapy. Pharmacogenomics. 12(12). 1729–1740. 12 indexed citations
16.
Sarrazin, Christoph, S. Süsser, Alexandra Doehring, et al.. (2010). Importance of IL28B gene polymorphisms in hepatitis C virus genotype 2 and 3 infected patients. Journal of Hepatology. 54(3). 415–421. 191 indexed citations
17.
Doehring, Alexandra, Wolf Peter Hofmann, Christina Schlecker, et al.. (2010). Screening forIL28Bgene variants identifies predictors of hepatitis C therapy success. Antiviral Therapy. 15(8). 1099–1106. 18 indexed citations
18.
Rieger, Ulrich M., Christina Schlecker, Gerhard Pierer, & Martin Haug. (2009). Spontaneous Regression of Two Giant Basal Cell Carcinomas in a Single Patient after Incomplete Excision. Tumori Journal. 95(2). 258–263. 7 indexed citations
19.
Schlecker, Christina, Wolfgang Boehmerle, Andreas Jeromin, et al.. (2006). Neuronal calcium sensor-1 enhancement of InsP3 receptor activity is inhibited by therapeutic levels of lithium. Journal of Clinical Investigation. 116(6). 1668–1674. 117 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Giorgia Valle Breakdown of academic impact, for papers by Richard M. Roman Breakdown of academic impact, for papers by Pascale Bellaud Breakdown of academic impact, for papers by Scott M. Seki Breakdown of academic impact, for papers by Shintaro Okada Breakdown of academic impact, for papers by Sung‐Kyun Moon Breakdown of academic impact, for papers by Neomi Zurgil Breakdown of academic impact, for papers by B. Schwartz Breakdown of academic impact, for papers by Tao Yin Breakdown of academic impact, for papers by Eva Schmitteckert
Rankless by CCL
2026